- Home
- IMUX vs TBNK Comparison
IMUX vs TBNK Comparison
Compare IMUX & TBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- TBNK
- Stock Information
- Founded
- IMUX 2016
- TBNK 1921
- Country
- IMUX United States
- TBNK United States
- Employees
- IMUX N/A
- TBNK N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- TBNK Savings Institutions
- Sector
- IMUX Health Care
- TBNK Finance
- Exchange
- IMUX Nasdaq
- TBNK Nasdaq
- Market Cap
- IMUX 86.3M
- TBNK 70.9M
- IPO Year
- IMUX N/A
- TBNK N/A
- Fundamental
- Price
- IMUX $1.27
- TBNK $8.28
- Analyst Decision
- IMUX Strong Buy
- TBNK Hold
- Analyst Count
- IMUX 6
- TBNK 2
- Target Price
- IMUX $12.67
- TBNK $9.89
- AVG Volume (30 Days)
- IMUX 795.3K
- TBNK 7.5K
- Earning Date
- IMUX 03-04-2025
- TBNK 01-31-2025
- Dividend Yield
- IMUX N/A
- TBNK 0.48%
- EPS Growth
- IMUX N/A
- TBNK N/A
- EPS
- IMUX N/A
- TBNK N/A
- Revenue
- IMUX N/A
- TBNK $36,403,000.00
- Revenue This Year
- IMUX N/A
- TBNK N/A
- Revenue Next Year
- IMUX N/A
- TBNK $14.93
- P/E Ratio
- IMUX N/A
- TBNK N/A
- Revenue Growth
- IMUX N/A
- TBNK N/A
- 52 Week Low
- IMUX $0.92
- TBNK $6.92
- 52 Week High
- IMUX $2.11
- TBNK $11.44
- Technical
- Relative Strength Index (RSI)
- IMUX 72.48
- TBNK 32.63
- Support Level
- IMUX $0.92
- TBNK $8.61
- Resistance Level
- IMUX $1.15
- TBNK $8.87
- Average True Range (ATR)
- IMUX 0.07
- TBNK 0.18
- MACD
- IMUX 0.03
- TBNK -0.02
- Stochastic Oscillator
- IMUX 74.47
- TBNK 0.00
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.